{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:39:42Z","timestamp":1791311982994,"version":"4.3.1"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T00:00:00Z","timestamp":1211328000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:bold>Objectives:<\/jats:bold> Chronic subacute inflammation is implicated in the pathogenesis of insulin resistance and type 2 diabetes. Salicylates were shown years ago to lower glucose and more recently to inhibit NF\u2010\u03baB activity. Salsalate, a prodrug form of salicylate, has seen extensive clinical use and has a favorable safety profile. We studied the efficacy of salsalate in reducing glycemia and insulin resistance and potential mechanisms of action to validate NF\u2010\u03baB as a potential pharmacologic target in diabetes.<\/jats:p><jats:p> <jats:bold>Methods and Results:<\/jats:bold> In open label studies, both high (4.5 g\/d) and standard (3.0 g\/d) doses of salsalate reduced fasting and postchallenge glucose levels after 2 weeks of treatment. Salsalate increased glucose utilization during euglycemic hyperinsulinemic clamps, by approximately 50% and 15% at the high and standard doses, respectively, and insulin clearance was decreased. Dose\u2010limiting tinnitus occurred only at the higher dose. In a third, double\u2010masked, placebo\u2010controlled trial, 1 month of salsalate at maximum tolerable dose (no tinnitus) improved fasting and postchallenge glucose levels. Circulating free fatty acids were reduced and adiponectin increased in all treated subjects.<\/jats:p><jats:p> <jats:bold>Conclusions:<\/jats:bold> These data demonstrate that salsalate improves in vivo glucose and lipid homeostasis, and support targeting of inflammation and NF\u2010\u03baB as a therapeutic approach in type 2 diabetes.<\/jats:p>","DOI":"10.1111\/j.1752-8062.2008.00026.x","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T15:23:00Z","timestamp":1211383380000},"page":"36-43","source":"Crossref","is-referenced-by-count":257,"title":["Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes"],"prefix":"10.1111","volume":"1","author":[{"given":"Allison B.","family":"Goldfine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Aldhahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tatro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongsoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Shoelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,5,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.4.917"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1882"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.12.9047"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01137"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1061620"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1166"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319246"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319451"},{"key":"e_1_2_7_13_2","first-page":"337","article-title":"Zur therapie des diabetes mellitus, insbesondere uber die anwendeng der salicylauren natron bei demselben","volume":"13","author":"Ebstein W","year":"1876","journal-title":"Berliner Klinische Wochenschrift"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1194485"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.2100.760"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5053.1071"},{"key":"e_1_2_7_17_2","first-page":"418","article-title":"Reappraisal of the hypoglycemic action of acetylsalicylate","volume":"8","author":"Hecht A","year":"1959","journal-title":"Metabolism"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.9.5.392"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.5.1.64"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0895-637"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8052854"},{"issue":"10","key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.156.10.3961","article-title":"Salicylates inhibit I kappa B\u2010alpha phosphorylation, endothelial\u2010leukocyte adhesion molecule expression, and neutrophil transmigration","volume":"156","author":"Pierce JW","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.09.027"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/23948"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214955"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(91)90165-S"},{"issue":"1","key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/028418517101100107","article-title":"Effects of salicylates on the gastric mucosa as revealed by roentgen examination and the gastrocamera","volume":"11","author":"Edmar D","year":"1971","journal-title":"Acta Radiol Diagn (Stockh)"},{"issue":"12","key":"e_1_2_7_28_2","first-page":"1570","article-title":"An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen","volume":"16","author":"Lanza F","year":"1989","journal-title":"J Rheumatol"},{"issue":"4","key":"e_1_2_7_29_2","first-page":"11","article-title":"Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study","volume":"19","author":"Roth S","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.12.1039"},{"issue":"4","key":"e_1_2_7_31_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1152\/jappl.1976.41.4.565","article-title":"Effects of arterial versus venous sampling on analysis of glucose kinetics in man","volume":"41","author":"McGuire EA","year":"1976","journal-title":"J Appl Physiol"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(89)90129-7"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(88)90110-2"},{"key":"e_1_2_7_35_2","first-page":"105","article-title":"Activation of nuclear factor\u2010kappa B (NF\u2010kappa B) in mononuclear cells (MNC)","volume":"196","author":"Aljada A","year":"2002","journal-title":"Methods Mol Biol"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000142055.53122.FA"},{"issue":"7","key":"e_1_2_7_37_2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/diab.27.7.750","article-title":"Restoration of the acute insulin response by sodium salicylate. A glucose dose\u2010related phenomenon","volume":"27","author":"Chen M","year":"1978","journal-title":"Diabetes"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.33.9.872"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.7.3257"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.1.450"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001-1138"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90268-2"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1281928"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206083200"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307878200"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000083488.67550.B8"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1306"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032103"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03988"},{"issue":"3","key":"e_1_2_7_50_2","first-page":"321","article-title":"Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?","volume":"16","author":"The Multicenter Salsalate\/Aspirin Comparison Study Group","year":"1989","journal-title":"J Rheumatol"},{"issue":"4","key":"e_1_2_7_51_2","first-page":"20","article-title":"Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis?","volume":"19","author":"April P","year":"1990","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1752-8062.2008.00026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1752-8062.2008.00026.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:54:01Z","timestamp":1697392441000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/j.1752-8062.2008.00026.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1752-8062.2008.00026.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1752-8062.2008.00026.x","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}